Day: December 14, 2022

Majority of Stockholders Support Pasithea Directors at Special Meeting

Majority of Stockholders Support Pasithea Directors at Special Meeting

MIAMI BEACH, Fla., Dec. 14, 2022 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders, today announced the final results of the Special Meeting of Stockholders (“Special Meeting”) held on December 9, 2022. According to the certified voting results provided by the Independent Inspector of Elections, a significant majority of Pasithea stockholders rejected all of the proposals asserted by a dissident group of stockholders. Of the votes cast at the Special Meeting, approximately 67% rejected the proposals to remove the Company’s directors, representing approximately 12.7 million shares or approximately 44% of the total outstanding shares. As a result,...

Continue reading

Maha Energy AB (publ) successfully completes a directed new share issue of 23,900,000 shares and raises proceeds of approximately SEK 203 million

Maha Energy AB (publ) successfully completes a directed new share issue of 23,900,000 shares and raises proceeds of approximately SEK 203 million

NOT FOR RELEASE, DISTRIBUTION, PUBLICATION, DIRECTLY OR INDIRECTLY IN WHOLE OR IN PART IN THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA, BELARUS OR ANY JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Maha Energy AB (publ) (“Maha” or the “Company”) has, in accordance with the Company’s press release earlier today, completed an accelerated bookbuilding procedure and resolved on a directed new share issue of 23,900,000 shares at a subscription price of SEK 8.5 per share (the “Directed New Share Issue”). The subscription price for the shares in the Directed New Share Issue has been determined through an accelerated bookbuilding procedure carried out...

Continue reading

Noranda Income Fund Successfully Completes Major Cellhouse Repairs and Restarts Operations

Noranda Income Fund Successfully Completes Major Cellhouse Repairs and Restarts Operations

TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX:NIF.UN) (the “Fund”) today provided an update regarding the successful completion of the maintenance shutdown and recommissioning of its electrolytic zinc processing facility (the “Processing Facility”) located in Salaberry-de-Valleyfield, Quebec. As previously announced, the Fund temporarily shut down operations to proceed with a proactive cell repair program and a cell-by-cell integrity assessment aimed at mitigating risk in the cellhouse. The shutdown lasted approximately six weeks, following which the facility went through a recommissioning phase. The Fund expects to benefit from the findings of its cell-by-cell integrity assessment as it continues the execution of its repair and maintenance program. “Various levels of repairs were made to the cells in the cellhouse...

Continue reading

AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023

AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023

RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that the December 13th, 2022, Annual Meeting is being adjourned until January 12th, 2023, to provide stockholders with additional time to vote on Proposal 1, approval of an amendment to the Company’s Certificate of Incorporation to increase the total number of authorized shares of Common Stock. This vote, which requires approval by a majority of the outstanding shares, is required to proceed with the proposed merger with Viewpoint Molecular Targeting, Inc. The Board of Directors, as well as leading proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co.,...

Continue reading

Noranda Income Fund Sets Date for Unitholder Meeting

Noranda Income Fund Sets Date for Unitholder Meeting

TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX:NIF.UN) (the “Fund”) announced today that a special meeting of unitholders (the “Meeting”) will be held on March 28, 2023 in response to the meeting requisition notice received from certain unitholders, including Riverstyx Capital Management and LM Asset Fund Limited Partnership, dated November 24, 2022. Over the last week, independent members of the Board of Trustees (the “Board”) of the Noranda Operating Trust (the “Trust”) initiated engagement with Riverstyx Capital Management and LM Asset Fund Limited Partnership. The goal was to come to a shared understanding and identify a mutually agreeable path forward. While no such path as yet has been agreed, the Trust’s Board regularly engages in conversations with unitholders and remains open to maintaining a dialogue...

Continue reading

Firm Capital Mortgage Investment Corporation Announces Estimated Special and Regular Dividend for December 2022, and Regular Dividends for January through to March of 2023

Firm Capital Mortgage Investment Corporation Announces Estimated Special and Regular Dividend for December 2022, and Regular Dividends for January through to March of 2023

TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation“) (TSX: FC) announces that its board of directors has declared and approved its monthly cash dividend on its outstanding common shares for December 2022 of $0.078 per share. The Corporation also announces an estimated special year-end cash dividend (the “Special Dividend”) on its outstanding common shares of $0.014 per share. These cash dividends, totaling an estimated $0.092 per share, are payable on or about January 16, 2023, to holders of shares of record at the close of business on December 31, 2022. The precise amount of the Special Dividend will be confirmed prior to the payment date. The Special Dividend recognizes that the (estimated) annual income generated in 2022 is expected to exceed the regular monthly...

Continue reading

Euro Sun Announces Closing of Second Tranche of Private Placement

Euro Sun Announces Closing of Second Tranche of Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES NOT FOR RELEASE IN THE UNITED STATES OR TO U.S. NEWS WIRE SERVICES TORONTO, Dec. 14, 2022 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that it has closed the second tranche (the “Second Tranche”) of its previously announced non-brokered private placement financing (the “Offering”). An aggregate of 2,500,000 common shares (the “Common Shares”) were sold under the Second Tranche at a price of C$0.05 per Common Share for aggregate gross proceeds of approximately C$125,000. Euro Sun intends to use the proceeds of the Offering for general corporate purposes. All securities issued in connection with the Offering are subject to a statutory hold period of four-months and one day. The...

Continue reading

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

embecta to Participate at the 41st Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) — Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2023 at 9:45 a.m. PT / 12:45 p.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company’s investor relations website at investors.embecta.com. About embecta embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com. CONTACTS  Investors:Pravesh...

Continue reading

Optimum Ventures Ltd. Announces Filing of NI 43-101 Technical Report and Closing of Definitive Agreement to Acquire Alaska Mineral Claims

Optimum Ventures Ltd. Announces Filing of NI 43-101 Technical Report and Closing of Definitive Agreement to Acquire Alaska Mineral Claims

VANCOUVER, British Columbia, Dec. 14, 2022 (GLOBE NEWSWIRE) — Optimum Ventures Ltd. (“Optimum” or the “Company”) (TSXV:OPV), is pleased to announce that the Company has closed its previously announced share exchange agreement dated November 24, 2022 (the “Agreement”) with all of the shareholders of 1309762 B.C. Ltd. (the “Vendor”), a privately held corporation incorporated under the laws of British Columbia, pursuant to which the Company acquired all of the issued and outstanding common shares from the shareholders of Vendor in exchange for 3,000,000 common shares of the Company (“Optimum Shares”) subject to the terms and conditions set out in the Agreement (the “Transaction”). The Vendor owns 19 contiguous mining claims forming the Salmon Property covering approximately 208 hectares in the Hyder Mining District situated in southeastern...

Continue reading

Ocean Power Technologies, Inc. Announces Second Quarter Fiscal 2023 Results

Ocean Power Technologies, Inc. Announces Second Quarter Fiscal 2023 Results

MONROE TOWNSHIP, N.J., Dec. 14, 2022 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American: OPTT), a leader in innovative and cost-effective low-carbon marine data, power, and consulting service solutions, today announced financial results for its second quarter ended October 31, 2022 (“2Q23”). 2Q23 HIGHLIGHTS: Total orders for the 2Q23 were $2.3 million, as compared to $0.1 million for the second quarter ended October 31, 2021 (“2Q22”). Total orders for the six months ended 2Q23 were $2.9 million, comparing favorably to total orders of $0.6 million for the 2Q22. Delivered gross margin of $0.2 million through the six months ended October 31, 2022 as compared to a gross loss of $(0.2) million through the six months ended October 31, 2021 Revenues of $0.3 million for the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.